Diagnostic Strategies for Prostate Cancer Bob Djavan, Amir Kazzazi, Lori Dulabon, Markus Margreiter, Alexander Farr, Markus Johannes Handl, Herbert Lepor  European Urology Supplements  Volume 10, Issue 3, Pages e26-e37 (May 2011) DOI: 10.1016/j.eursup.2011.03.010 Copyright © 2011 Terms and Conditions

Fig. 1 American Urological Association guideline for early detection of prostate cancer. Modified from Prostate-Specific Antigen Best Practice Statement: 2009 Update (American Urological Association Education and Research, Inc, 2009) [19]. PSA=prostate-specific antigen; DRE=digital rectal examination; BPH=benign prostatic hypertrophy. European Urology Supplements 2011 10, e26-e37DOI: (10.1016/j.eursup.2011.03.010) Copyright © 2011 Terms and Conditions

Fig. 2 The prostate risk indicator (http://www.prostatecancer-riskcalculator.com/via.html). PSA=prostate-specific antigen. European Urology Supplements 2011 10, e26-e37DOI: (10.1016/j.eursup.2011.03.010) Copyright © 2011 Terms and Conditions

Fig. 3 Artificial neural network architecture for diagnosis of prostate cancer on repeat biopsy. Reproduced with permission from Springer-Verlag [89]. PSA=prostate-specific antigen; f/tPSA=ratio of free to total PSA; TOT=total prostate volume; TZ=transitional zone; PSAD=PSA density. European Urology Supplements 2011 10, e26-e37DOI: (10.1016/j.eursup.2011.03.010) Copyright © 2011 Terms and Conditions